$8.01
0.02% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
CA74319B5027
Symbol
PROF

Profound Medical Corp Stock price

$8.01
+0.38 4.98% 1M
-0.53 6.21% 6M
-0.48 5.65% YTD
-1.43 15.15% 1Y
-4.05 33.58% 3Y
-0.69 7.93% 5Y
-2.18 21.35% 10Y
Nasdaq, Closing price Fri, Nov 15 2024
-0.00 0.02%
ISIN
CA74319B5027
Symbol
PROF
Sector

Key metrics

Market capitalization $197.54m
Enterprise Value $176.65m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 19.67
P/S ratio (TTM) P/S ratio 22.00
P/B ratio (TTM) P/B ratio 6.36
Revenue growth (TTM) Revenue growth 39.35%
Revenue (TTM) Revenue $8.98m
EBIT (operating result TTM) EBIT $-33.09m
Free Cash Flow (TTM) Free Cash Flow $-24.49m
Cash position $27.12m
EPS (TTM) EPS $-1.34
P/E forward negative
P/S forward 17.53
EV/Sales forward 15.66
Short interest 2.71%
Show more

Is Profound Medical Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Profound Medical Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Profound Medical Corp forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a Profound Medical Corp forecast:

Buy
100%

Financial data from Profound Medical Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
8.98 8.98
39% 39%
100%
- Direct Costs 3.41 3.41
33% 33%
38%
5.57 5.57
44% 44%
62%
- Selling and Administrative Expenses 21 21
38% 38%
237%
- Research and Development Expense 16 16
20% 20%
181%
-32 -32
28% 28%
-356%
- Depreciation and Amortization 1.16 1.16
5% 5%
13%
EBIT (Operating Income) EBIT -33 -33
27% 27%
-368%
Net Profit -31 -31
8% 8%
-350%

In millions USD.

Don't miss a Thing! We will send you all news about Profound Medical Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Profound Medical Corp Stock News

Neutral
Seeking Alpha
6 days ago
Profound Medical Corporation (NASDAQ:PROF ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Stephen Kilmer - IR Arun Menawat - CEO Rashed Dewan - CFO Mathieu Burtnyk - COO Conference Call Participants Benjamin Haynor - Lake Street Capital Markets John Baugh - Stifel Michael Freeman - Raymond James Scott McAuley - Paradigm Capital Operator Good day and thank you...
Neutral
GlobeNewsWire
12 days ago
– TULSA to stand above all other covered prostate disease treatment modalities at Urology Level 7 reimbursement – – First-time CPT® code reimbursement for TULSA to be effective January 1, 2025 – TORONTO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, ...
Neutral
GlobeNewsWire
29 days ago
TORONTO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its third quarter 2024 financial results after market close on Thursday, November 7, 2024.
More Profound Medical Corp News

Company Profile

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.

Head office Canada
CEO Arun Menawat
Employees 131
Founded 2008
Website www.profoundmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today